WorldStage Newwsonline– GlaxoSmithKline Consumer Nigeria Plc on Thursday announced changes on its board with the acceptance of the resignation of Mr. Basel Nizameddinas a Non-Executive Director from 29th July 2020.
The company in a note to the Nigerian Stock Exchange signed by Uche Uwechia, Company Secretary also confirmed the appointment of Mr. Oussama Abbas as a non- executive director on the board of the Company effective 29th July 2020.
According to the note, Nizameddin resignation was accepted at the emergency meeting of the Board of Directors of GlaxoSmithKline Consumer Nigeria Plc held on 29th July 2020 at GSK House, 1, Industrial Avenue, Ilupeju, Lagos.
Mr. Nizameddin’s resignation was said to be necessary to enable him attend to other new assignments within the GSK Group.
“The Board acknowledged the strong contributions of Mr. Nizameddin to the Board and wished him the best in his future endeavours,” the note said.
On Abbas, the non- executive director, he is said to be “currently Head of Supply Chain – Turkey, Middle East & Africa (MEA), Consumer Health Supply Chain (CHSC), is an accomplished industrial senior executive of GSK with proven abilities in international pharmaceutical, biotech and animal healthcare. He also has solid experience in leading manufacturing plants of commercial and clinical supply-chain operations.
“He is deeply involved in corporate organizational changes with understanding of impact on other business functions.
“Mr. Abbas has an International Executive MBA (High Distinction) from the Louvain School of Management – Belgium (1999); Doctorate Degree, Faculty of Pharmacy – University Claude Bernard (Lyon – France); Second Degree Master – Focus in Galenic (Formulation – Process – Production) – University Diploma of Pharmaceutical Management, Institut de la Pharmacie Industrielle de Lyon.
“He joined GSK as Director, Secondary Manufacturability & Clinical Supply in May 2009 and has grown through the system to his current position as the Head of Supply Chain of MEA.
“The Board is very confident that with his background, relevant experience and significant involvement in the Global Supply Chain network, Mr. Oussama Abbas would add significant value to the quality and diversity of the Board of GlaxoSmithKline Consumer Nigeria Plc.”
